3 Recruiting Metastatic Non Small Cell Lung Cancer Phase 3 Clinical Trials

Active phase 3 studies for metastatic non small cell lung cancer enrolling across the USA. Verify eligibility and contact site coordinators.

All Metastatic Non Small Cell Lung Cancer studies

Phase 3 Studies for Metastatic Non Small Cell Lung Cancer

🔵 Active, Not Recruiting Phase3

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

📍 Local Institution - 012-898 — Cerritos, California

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3

Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

📍 Ironwood Cancer and Research Center — Chandler, Arizona

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

📍 Southern Cancer Center Pc — Daphne, Alabama

View Study & Checklist ➔